Sweeteners
aspartame increases cancer risk
Part of: • aspartame
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Aspartame was classified by IARC (2023) as 'possibly carcinogenic to humans' (Group **2B**) — a category for *limited* evidence that flags a hazard, not a quantified risk. Human epidemiology is largely reassuring: the Nurses' Health Studies found no breast-cancer link (HR 1.00), reviews find no consistent association, and JECFA reaffirmed the 40 mg/kg/day acceptable intake. The notable exception i
The evidence (10)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Pavanello et al. 2023 · Regul Toxicol Pharmacol | observational | contradicts | moderate | Tox + epi review incl. aspartame genotoxicity/carcinogenicity data: no evidence of cancer risk. |
| Li et al. 2024 · Br J Nutr | meta-analysis | mixed | moderate | MA: non-nutritive sweeteners not associated with endometrial cancer. |
| Yan et al. 2022 · Nutrients | meta-analysis | mixed | moderate | MA: aspartame subgroup showed a significant cancer association in some analyses, though overall artificial-sweetener effect was null. |
| Zhu et al. 2026 · J Nutr | observational | mixed | moderate | Large prospective cohort: aspartame–cancer evidence inconsistent, particularly for obesity-related cancers. |
| Shaher et al. 2023 · Nutrients | observational | mixed | low | Aspartame safety review: epi signals for NHL/myeloma in males; carcinogenicity debate ongoing, chance not excluded. |
| Romanos-Nanclares et al. 2025 · J Natl Cancer Inst | observational | contradicts | high | Nurses' Health Studies: no aspartame–breast-cancer association (HR 1.00 per 200 mg/d), robust to lag analyses. |
| Debras et al. 2022 · PLoS Med | observational | supports | moderate | NutriNet-Santé: aspartame intake associated with slightly higher overall cancer risk (notably breast and obesity-related cancers). |
| Marchitti et al. 2025 · Adv Nutr | meta-analysis | contradicts | high | Animal/mechanistic review: no genotoxic/carcinogenic mode of action for aspartame. |
| Haighton et al. 2019 · Regul Toxicol Pharmacol | observational | contradicts | moderate | Quality-appraised aspartame cancer epidemiology: does not support an increased cancer risk in humans. |
| Zhu et al. 2024 · Med Princ Pract | meta-analysis | mixed | moderate | MA: artificial sweeteners not associated with higher colorectal cancer. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.